Börskollen
Pressmeddelanden från Stenocare
26 feb 08:00
StenocareInterim report fourth quarter and Financial Statement Release 202511 feb 08:00StenocareSTENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership27 jan 16:27StenocareStenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany30 dec 2025 11:19StenocareTrading in STENOCARE shares by closely related party to board member19 nov 2025 19:56StenocareSTENOCARE share analyst’s comments on the CannGros acquisition18 nov 2025 09:59StenocareCorrection of total shares issued and total nominal share capital:17 nov 2025 17:56StenocareSTENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal17 nov 2025 17:01StenocareSTENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal22 okt 2025 08:00StenocareInterim report third quarter 202527 aug 2025 21:30StenocareTrading in STENOCARE shares by closely related party to board member21 aug 2025 08:00StenocareInterim report second quarter 202515 maj 2025 11:36StenocareCommuniqué from the Annual General Meeting of STENOCARE08 maj 2025 08:00StenocareInterim report first quarter 202502 maj 2025 14:35StenocareMedical Cannabis Made Permanent in Denmark: Major Milestone for Patients and STENOCARE22 apr 2025 15:01StenocareNotice to Annual General Meeting in STENOCARE A/S03 apr 2025 08:00StenocareSTENOCARE ASTRUM 10-10 Oil Product Approved for Reimbursement in Germany31 mar 2025 08:00StenocareSTENOCARE Begins Sales of New CBD100 Oil Product in Denmark28 mar 2025 13:25StenocareSTENOCARE interview with Proinvestor.com – Annual Report 202427 mar 2025 08:01StenocareSTENOCARE A/S publishes Annual Report 202427 feb 2025 09:04StenocareQ4 and Annual Financial Statement Release 202414 feb 2025 08:56StenocareSTENOCARE – The innovative ASTRUM 10-10 product is now available for Australian patients29 jan 2025 10:52StenocareSTENOCARE A/S Embarks on Strategic Transformation with HQ Relocation and Cultivation Facility Exit22 jan 2025 12:37StenocareSTENOCARE A/S: Conditional Rights Issue subscribed to 45.0 percent20 jan 2025 12:29StenocareSTENOCARE – Final deadline for Subscription to New Shares at DKK 0.50 Each17 jan 2025 08:00StenocareSTENOCARE – Final deadline Soon for Subscription to New Shares at DKK 0.50 Each15 jan 2025 11:57StenocareSTENOCARE – The new innovative ASTRUM 10-10 product is now available for German patients15 jan 2025 08:00StenocareSTENOCARE - Deadline Soon for Subscription to New Shares at DKK 0.50 Each10 jan 2025 17:03StenocareSTENOCARE A/S announces guarantee commitments in ongoing rights issue09 jan 2025 19:55StenocareSTENOCARE – Deadline soon to subscribe for new shares at DKK 0.50 each07 jan 2025 11:22StenocareSTENOCARE A/S: The subscription period in Stenocare’s conditional rights issue begins today for the time limited offer of DKK 0,50 per new share03 jan 2025 11:21StenocareSTENOCARE’s Innovative ASTRUM 10-10 Product Now Available for Norwegian Patients18 dec 2024 19:00StenocareSTENOCARE A/S: Conditional Rights Issue of up to 20.2 mDKK18 dec 2024 13:37StenocareCommuniqué from extraordinary general meeting in STENOCARE17 dec 2024 08:00StenocareSTENOCARE Gains Danish Approval for New Medical Cannabis CBD100 oil10 dec 2024 15:38StenocareSTENOCARE 3.0 Strategy: Management Shares Insights in Exclusive Interview with Proinvestor.com02 dec 2024 08:00StenocareSTENOCARE – Innovative New ASTRUM Product Officially Approved for Sale in Norway28 nov 2024 22:14StenocareSTENOCARE Celebrates Denmark’s Permanent Legalisation of Medical Cannabis26 nov 2024 17:46StenocareSTENOCARE 3.0: Shifting Strategy to Focus on Trading and exit from Production26 nov 2024 17:11StenocareNotice to Extraordinary General Meeting in STENOCARE A/S19 nov 2024 13:09StenocareSTENOCARE Welcomes Danish Health Minister’s Decision to Permanently Legalise Medical Cannabis for Patients05 nov 2024 13:31StenocareInterim Report Third Quarter 202401 nov 2024 13:31StenocareSTENOCARE Change in the Board of Directors14 okt 2024 08:00StenocareSTENOCARE updates guidance for 202421 aug 2024 08:00StenocareInterim Report Second Quarter 202420 aug 2024 08:00StenocareSTENOCARE updates guidance for 202431 jul 2024 15:40StenocareNew innovative Stenocare Astrum 10-10 oil product is ready for sale in Germany28 jun 2024 17:17StenocareSTENOCARE A/S: Directed issue, refinancing of debt from a major shareholder and new dates25 jun 2024 14:01StenocareTO2 Warrant Exercise subscribed to 88.3%20 jun 2024 08:00StenocareSTENOCARE: Notice for deadline of subscribing at the discounted price of DKK 3.16 per share18 jun 2024 13:31StenocareSTENOCARE A/S: Notice for deadline of trading TO2 Warrants17 jun 2024 11:27StenocareSTENOCARE is expanding into Canada13 jun 2024 16:25StenocareSTENOCARE A/S: Publication of investment brochure12 jun 2024 12:40StenocareSTENOCARE is shortlisted for European Cannabis Company of the Year07 jun 2024 18:48StenocareSTENOCARE A/S: Announcement of Exercise Price of Warrants of Series TO231 maj 2024 10:04StenocareAn Update on STENOCARE's Strong Product Pipeline23 maj 2024 13:12StenocareSTENOCARE launch next generation medical cannabis oil product in Australia – six months ahead of schedule22 maj 2024 12:22StenocareSTENOCARE is sharing early information about the upcoming share issue “TO2 Warrant” transaction in June 202414 maj 2024 17:16StenocareCOMMUNIQUE FROM THE ANNUAL GENERAL MEETING OF STENOCARE02 maj 2024 08:00StenocareInterim Report First Quarter 202422 apr 2024 16:00StenocareNotice to Annual General Meeting in STENOCARE A/S18 apr 2024 09:11StenocareFrom today, the new STENOCARE THC/CBD medical cannabis oil product is available for sale in Denmark14 mar 2024 08:00StenocareSTENOCARE A/S publishes Annual Report 202312 mar 2024 08:00StenocareNew Stenocare product ready for sale in Australia26 feb 2024 13:46StenocareMajor milestone reached: STENOCARE receives approval to sell a new medical cannabis oil product in Denmark22 feb 2024 08:00StenocareInterim Report Fourth Quarter 202305 feb 2024 15:43StenocareCommuniqué from extraordinary general meeting in STENOCARE12 jan 2024 15:48StenocareSTENOCARE financing need has been completed as planned incl solution for refinancing of debt12 jan 2024 15:44StenocareNotice to Extraordinary General Meeting in STENOCARE A/S29 dec 2023 12:11StenocareSTENOCARE: How to receive TO1 Warrant Compensation21 dec 2023 17:26StenocareSTENOCARE A/S: Consolidation of founder’s shareholdings21 dec 2023 15:41StenocareTO1 Warrant Exercise subscribed to 76.7%19 dec 2023 20:04StenocareFounders of Stenocare join directed issue19 dec 2023 08:00StenocareShareholder invests 4.7 mDKK in STENOCARE A/S17 dec 2023 21:54StenocareSTENOCARE: The deadline for using TO1 Warrants is Dec 1914 dec 2023 10:34StenocareSTENOCARE expands in Australia13 dec 2023 17:48StenocareSTENOCARE: The deadline for trading TO1 Warrants is Dec 1511 dec 2023 08:00StenocareSTENOCARE Executive team to exercise TO1 Warrants06 dec 2023 08:30StenocareSTENOCARE A/S: Announcement of Exercise Price of Warrants of Series TO104 dec 2023 08:01StenocareSTENOCARE confirms guidance and reports limited capital requirements ahead of the first TO1-warrant subscription starting on 6 December 202329 nov 2023 16:41StenocareAmended terms relating to upcoming TO1 and TO2 warrants23 nov 2023 07:59StenocareAustralia due to become a major market for STENOCARE in 202409 nov 2023 08:00StenocareInterim Report Third Quarter 202306 nov 2023 13:39StenocareUpdated guidance: Record sales in 2023 and break-even in 202406 nov 2023 13:38StenocareSTENOCARE: One-off return of products from Norway30 okt 2023 08:25StenocareSTENOCARE ready to ship medical cannabis to German patients27 sep 2023 08:00StenocareSignificant growth in market share and patients in Denmark18 sep 2023 11:57StenocareSTENOCARE market update – September 202301 sep 2023 08:00StenocareSTENOCARE’s commitment to supply medical cannabis to patients17 aug 2023 08:00StenocareInterim Report Second Quarter 202327 jul 2023 12:56StenocareSTENOCARE update on their strong Danish product pipeline26 jun 2023 16:55StenocareSTENOCARE A/S: Conversion of 5.0 mDKK of debt20 jun 2023 08:00StenocareInterim Report First Quarter 202313 jun 2023 18:33StenocareCommuniqué from extraordinary general meeting in STENOCARE12 jun 2023 11:25StenocareSTENOCARE Units Rights Issue subscribed to 127%06 jun 2023 08:00StenocareHigh profiled medical doctor and entrepreneur joins STENOCARE’s ongoing share-issue05 jun 2023 08:00StenocareSTENOCARE deadlines for its ongoing Unit Right Issue: Last day for subscription for shares at DKK 4.58 each is Thursday June 802 jun 2023 12:56StenocareSTENOCARE reports on significant progress in development of its new innovative medical cannabis product30 maj 2023 08:00StenocareSTENOCARE launches groundbreaking IT-platform for Online Clinics25 maj 2023 08:00StenocareSTENOCARE PRODUCT APPROVED AND READY FOR SALE IN GERMANY24 maj 2023 08:02StenocareSTENOCARE företrädesemission med Units – startar i dag
StenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocareStenocare